Omnipod Pods Recalled

On May 26, 2026, Insulet Corporation initiated a voluntary recall of specific lots of Omnipod^® 5 pods, Omnipod DASH^® pods, and Omnipod^® Insulin Management System (Omnipod Eros) pods. The recall was prompted by a potential device malfunction that may result in interruption or under-delivery of insulin, including medically significant outcomes such as hyperglycemia and risk of diabetic ketoacidosis (DKA). Omnipod systems are FDA-cleared for the management of diabetes mellitus requiring continuous subcutaneous (SC) insulin infusion. Patients can check whether their pod lots are affected here. The FDA recall notice is available here.